Lilly shuffles business structure; Novartis writes off part of Avidity deal

Coverage, in order

1. 14d ago
   
   BioPharma Dive indie

   Lilly shuffles business structure; Novartis writes off part of Avidity deal

   Lilly intends to merge its U.S. and international divisions when a top executive retires. Elsewhere, Astellas closed in on what it believes to be a “best-in-class” cancer immunotherapy prospect.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.